CA2285477C - Formulations et procedes de traitement et de prevention de la myelo-encephalite equine due a des protozoaires - Google Patents

Formulations et procedes de traitement et de prevention de la myelo-encephalite equine due a des protozoaires Download PDF

Info

Publication number
CA2285477C
CA2285477C CA002285477A CA2285477A CA2285477C CA 2285477 C CA2285477 C CA 2285477C CA 002285477 A CA002285477 A CA 002285477A CA 2285477 A CA2285477 A CA 2285477A CA 2285477 C CA2285477 C CA 2285477C
Authority
CA
Canada
Prior art keywords
epm
treatment
diclazuril
triazine
horse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002285477A
Other languages
English (en)
Other versions
CA2285477A1 (fr
Inventor
David Granstrom
Thomas Tobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/908,257 external-priority patent/US5883095A/en
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of CA2285477A1 publication Critical patent/CA2285477A1/fr
Application granted granted Critical
Publication of CA2285477C publication Critical patent/CA2285477C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002285477A 1997-03-31 1998-03-31 Formulations et procedes de traitement et de prevention de la myelo-encephalite equine due a des protozoaires Expired - Lifetime CA2285477C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4247397P 1997-03-31 1997-03-31
US60/042,473 1997-03-31
US08/908,257 1997-08-07
US08/908,257 US5883095A (en) 1997-08-07 1997-08-07 Formulations and methods to treat and prevent equine protozoal myeloencephalitis
PCT/US1998/006340 WO1998043644A1 (fr) 1997-03-31 1998-03-31 Formulations et procedes de traitement et de prevention de la myelo-encephalite equine due a des protozoaires

Publications (2)

Publication Number Publication Date
CA2285477A1 CA2285477A1 (fr) 1998-10-08
CA2285477C true CA2285477C (fr) 2006-10-10

Family

ID=26719285

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002285477A Expired - Lifetime CA2285477C (fr) 1997-03-31 1998-03-31 Formulations et procedes de traitement et de prevention de la myelo-encephalite equine due a des protozoaires

Country Status (3)

Country Link
BR (1) BR9808114A (fr)
CA (1) CA2285477C (fr)
WO (1) WO1998043644A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
DE69906335T2 (de) * 1998-10-06 2004-02-12 Mars U.K. Ltd., Slough Verhaltensstörungen beim tier
GB9822681D0 (en) * 1998-10-16 1998-12-09 Vitabiotics Ltd Method of treatment
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
NZ512476A (en) * 1998-12-22 2003-08-29 Bayer Ag Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
US6884797B2 (en) * 2001-03-30 2005-04-26 Robert F. Hofmann Targeted oxidative therapeutic formulation
DE602004009664D1 (de) * 2003-01-16 2007-12-06 Janssen Pharmaceutica Nv Diclazurilhaltige antiprotozoenmittel
MX2008009818A (es) * 2008-07-31 2010-02-01 Avi Mex S A De C V Lab Combinacion coccidicida para uso veterinario.
US12564571B2 (en) 2018-02-20 2026-03-03 Going Big Time, Inc. Compositions and methods for the treatment of equine protozoal myeloencephalitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones

Also Published As

Publication number Publication date
WO1998043644A1 (fr) 1998-10-08
BR9808114A (pt) 2000-03-08
CA2285477A1 (fr) 1998-10-08

Similar Documents

Publication Publication Date Title
US5883095A (en) Formulations and methods to treat and prevent equine protozoal myeloencephalitis
EP1390049B1 (fr) Preparations de traitement de maladies et de syndromes animaux comprenant du facteur de transfer
AP387A (en) Therapeutical uses of L-methionine and compositions thereof.
US20040029941A1 (en) Zonisamide use in obesity and eating disorders
AU2002311871A1 (en) Compositions for treating animal diseases and syndromes
US5935591A (en) Method for treatment of equine protozoal myeloencephalitis with thiazolides
WO1998043644A1 (fr) Formulations et procedes de traitement et de prevention de la myelo-encephalite equine due a des protozoaires
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
McAllister et al. Sulphide-induced polioencephalomalacia in lambs
Shaw et al. High dietary chloride content associated with loss of therapeutic serum bromide concentrations in an epileptic dog
US6995190B2 (en) Method and treatment with ketoprofen solution
WO2016120787A1 (fr) N-acétylcystéine destinée à être administrée par voie orale dans le traitement d'infections des voies respiratoires supérieures et de symptômes associés
CN1221265C (zh) 用于治疗由肉孢子虫、新孢子虫和弓形虫引起的疾病的三嗪酮化合物
US6608033B1 (en) Treatment or prevention of coccidiosis
US20070292535A1 (en) Strontium compositions and methods of treating arthritic and or osteoporitic conditions
MXPA99008958A (en) Formulations and methods to treat and prevent equine protozoal myeloencephalitis
Stabler et al. Effect of 2-amino-5-nitrothiazole (enheptin) and other drugs on Trichomonas gallinae infection in the domestic pigeon
Whitlock Therapeutic strategies involving antimicrobial treatment of the gastrointestinal tract in large animals
JP2001081034A (ja) 動物用抗原虫剤
US20070292529A1 (en) Strontium compositions and methods of treating osteoporotic conditions
JP2020115853A (ja) ホスホジエステラーゼ３阻害用組成物及び血小板凝集抑制用組成物
RU2105548C1 (ru) Препарат "диарин" для лечения и профилактики желудочно-кишечных болезней молодняка животных
JPH04342528A (ja) アルコール代謝およびアセトアルデヒド代謝促進剤
EP2319515A1 (fr) Combinaison coccidicide à usage vétérinaire
EP3838347B1 (fr) Evernimicine pour traiter des maladies telles que l'entérite nécrotique

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180403